Market News AIOpen the app

SLS stock news · SELLAS Life Sciences Group Inc.

Stories about SELLAS Life Sciences Group Inc. (SLS) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for SLS

Follow SELLAS Life Sciences Group Inc. (SLS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SLS
Free on the App Store and Google Play, or on the web.
  1. Aug 31, 2026, 2:51 AM ET · Market

    BMF Capital questions SELLAS Life Sciences' nearly $3 billion valuation, labeling it as the biotech industry's "costliest gamble.

    Bad for SLS

    BMF Capital has raised concerns about SELLAS Life Sciences' nearly $3 billion valuation, suggesting it is overvalued ahead of the Phase 3 REGAL trial results, which could significantly impact the company's stock price if the trial fails.